The 20 Best Adult Soft Tissue Sarcoma Doctors Near Me in Falls Church, VA

Jeffrey Toretsky is a Hematologist and an Oncologist practicing medicine in Washington, Washington, D.c.. Dr. Toretsky is rated as an Elite provider by MediFind in the treatment of Adult Soft Tissue Sarcoma. He is also highly rated in 6 other conditions, according to our data. His clinical expertise encompasses Ewing Sarcoma, Osteosarcoma, Adult Soft Tissue Sarcoma, Rhabdomyosarcoma, and Bone Marrow Aspiration.

Paul Meltzer is a Hematologist and an Oncologist practicing medicine in Bethesda, Maryland. Dr. Meltzer is rated as an Elite provider by MediFind in the treatment of Adult Soft Tissue Sarcoma. He is also highly rated in 5 other conditions, according to our data. His clinical expertise encompasses Osteosarcoma, Adult Soft Tissue Sarcoma, Ewing Sarcoma, Rhabdomyosarcoma, and Pancreaticoduodenectomy.

John Feigert is a Hematologist and an Oncologist practicing medicine in Arlington, Virginia. Dr. Feigert is rated as a Distinguished provider by MediFind in the treatment of Adult Soft Tissue Sarcoma. He is also highly rated in 65 other conditions, according to our data. His clinical expertise encompasses Myelodysplastic Syndrome (MDS), Familial Colorectal Cancer, Multiple Myeloma, and Chronic Lymphocytic Leukemia (CLL).

Robert Christie is a Hematologist and an Oncologist practicing medicine in Arlington, Virginia. Dr. Christie is rated as a Distinguished provider by MediFind in the treatment of Adult Soft Tissue Sarcoma. He is also highly rated in 65 other conditions, according to our data. His clinical expertise encompasses Lung Cancer, Pleuropulmonary Blastoma, Paget Disease of the Breast, and Gastroenteropancreatic Neuroendocrine Tumor (GEP-NET).

Wohlscheid Director, Genitourinary Oncology Research Inova Schar Cancer Dr. Jeanny B. Aragon-Ching, MD, FACP, serves as the Clinical Program Director of Genitourinary Cancers at the Inova Schar Cancer Institute with a joint academic appointment as Associate Professor of Medical Education at the University of Virginia. Dr. Aragon-Ching joined Inova Schar Cancer Institute in 2015 to spearhead the GU Oncology program and bring together multidisciplinary expertise and advancement of research, clinical trial development, and personalized clinical care of patients with GU cancers. She has since served in the ASCO GU Program Planning Committee from 2017-2019, served as Track Chair for Urothelial cancers in 2018 and Renal Cell Cancer Track in 2016–2017 and member of the Prostate cancer track. She has chaired different sessions on bladder urothelial and non-urothelial cancers, kidney and prostate cancers. She also served in the ASCO Cancer Education Committee for the annual meeting for the GU non-prostate cancers. She is dedicated to the research and clinical care of patients with genitourinary cancers. Dr. Aragon-Ching completed her internship and residency at the Albert Einstein Medical Center in Philadelphia, PA, where she served the final year as Chief Resident. She later completed a Medical Oncology Fellowship at the National Cancer Institute, National Institutes of Health, in Bethesda, MD, where she served as an Associate Investigator on varying trials involved with pharmacogenomics and early drug discovery for genitourinary tumors. Dr. Aragon-Ching later moved to the George Washington University Medical Center in 2008 and was promoted to the rank of Associate Professor of Medicine in 2014. Her early research work focused on the use of angiogenesis inhibitors, bone-targeted agents, circulating tumor cells, clinical trial design and drug development. She has served in varying capacities as a peer reviewer, editorial board member and expert panel for highly acclaimed journals and congressionally directed research program grants. She is a well-published author and investigator of multiple GU trials, including prostate cancer, bladder cancer and kidney cancer trials. She is a well-established educator and serves on the editorial board of various academic journals. Dr. Aragon-Ching has chaired national meetings at the American Society of Clinical Oncology (ASCO) Genitourinary Cancers Symposium and has delivered esteemed presentations at the Society of Urologic Oncology, Best of ASCO, AUA, EAU, and the ASCO Annual meeting. She has also been previously named a “Top Doctor” by Washingtonian magazine and a “Best Doctor” by the Northern Virginia magazine. Dr. Aragon is rated as a Distinguished provider by MediFind in the treatment of Adult Soft Tissue Sarcoma. She is also highly rated in 15 other conditions, according to our data. Her clinical expertise encompasses Prostate Cancer, Urothelial Cancer, Bladder Cancer, Orchiectomy, and Prostatectomy.

Dr. Sekwon Jang is a specialty care physician board certified in internal medicine, hematology, and medical oncology. He has a special interest in management of melanoma and other skin cancers including cutaneous lymphoma. Dr. Jang serves as Director of Melanoma and Cutaneous Oncology Therapeutics and Research and Director of Quality at the Inova Schar Cancer Institute. Before joining Inova, Dr. Jang served as Assistant Professor of Medicine at Georgetown University School of Medicine and Co-Chair of melanoma research group at MedStar Georgetown Cancer Network. Dr. Jang believes in a covenant relationship with his patients, and his goal is to provide the best quality patient-centered care in the setting of multidisciplinary collaboration. Dr. Jang is rated as an Experienced provider by MediFind in the treatment of Adult Soft Tissue Sarcoma. He is also highly rated in 13 other conditions, according to our data. His clinical expertise encompasses Melanoma, Merkel Cell Carcinoma, Squamous Cell Skin Carcinoma, and Eccrine Porocarcinoma.

Dr. Nicole Laslett is a specialty care physician board certified in internal medicine, medical oncology, and hematology. She joined Inova in 2025 and has been practicing since 2015. Prior to joining Inova, Dr. Laslett served as a physician at Christiana Care Oncology Hematology at the Helen F. Graham Cancer Center and Research Institute in Newark, DE, where she was also a Core Faculty member. Additionally, she held academic appointments as a Clinical Assistant Professor of Medicine at both Thomas Jefferson University and the Philadelphia College of Osteopathic Medicine. Dr. Laslett is rated as an Advanced provider by MediFind in the treatment of Adult Soft Tissue Sarcoma. She is also highly rated in 12 other conditions, according to our data. Her clinical expertise encompasses Anal Cancer, Familial Colorectal Cancer, Paget Disease of the Breast, and Breast Cancer.

Keeran Sampat is a Hematologist and an Oncologist practicing medicine in Arlington, Virginia. Dr. Sampat is rated as an Advanced provider by MediFind in the treatment of Adult Soft Tissue Sarcoma. He is also highly rated in 54 other conditions, according to our data. His clinical expertise encompasses Anal Cancer, Familial Colorectal Cancer, Colorectal Cancer, and Paget Disease of the Breast.

Leslie Randall is an Oncologist and an Obstetrics and Gynecologist practicing medicine in Fairfax, Virginia. Dr. Randall is rated as an Advanced provider by MediFind in the treatment of Adult Soft Tissue Sarcoma. She is also highly rated in 14 other conditions, according to our data. Her clinical expertise encompasses Cervical Cancer, Ovarian Cancer, Endometrial Cancer, Malignant Mixed Mullerian Tumor, and Hysterectomy.

John Elkas is an Oncologist and an Obstetrics and Gynecologist practicing medicine in Fairfax, Virginia. Dr. Elkas is rated as an Advanced provider by MediFind in the treatment of Adult Soft Tissue Sarcoma. He is also highly rated in 17 other conditions, according to our data. His clinical expertise encompasses Endometrial Cancer, Endometrial Stromal Sarcoma, Malignant Mixed Mullerian Tumor, Oophorectomy, and Hernia Surgery.

Mather Director, Radiation Oncology Research Inova Radiation Oncology Inova Schar CancerDr. Avani Rao is a specialty care physician board certified in radiation oncology who serves as the Director of Research, Proton Therapy Fellowship Director and lead physician in pediatric radiation oncology. She joined Radiation Oncology Associates in 2020. Her areas of interest are pediatric, gynecologic, gastrointestinal and breast malignancies.Dr. Rao graduated from Yale University magna cum laude with a bachelor’s degree in molecular, cellular and developmental biology. She completed medical school, her internal medicine internship and her radiation oncology residency at Johns Hopkins School of Medicine. She was nominated to Alpha Omega Alpha during medical school, and during her residency, Dr. Rao served as Chief Resident. She pursued additional fellowship training at the University of Maryland to gain specific expertise in proton therapy. Dr. Rao has received several awards supporting her research and recognizing her clinical excellence and has published more than 40 peer-reviewed publications. Dr. Rao is board certified in radiation oncology. Dr. Rao is rated as an Advanced provider by MediFind in the treatment of Adult Soft Tissue Sarcoma. She is also highly rated in 38 other conditions, according to our data. Her clinical expertise encompasses Endometrial Stromal Sarcoma, Endometrial Cancer, Metastatic Brain Tumor, and Prostate Cancer.

Robert Reid is an Oncologist practicing medicine in Fairfax, Virginia. Dr. Reid is rated as an Advanced provider by MediFind in the treatment of Adult Soft Tissue Sarcoma. He is also highly rated in 55 other conditions, according to our data. His clinical expertise encompasses Lung Cancer, Pleuropulmonary Blastoma, Breast Cancer, Hormone Replacement Therapy (HRT), and Salpingo-Oophorectomy.

Dr. Michael Pishvaian is the director of Gastrointestinal, Developmental Therapeutics and Clinical Research Programs for the Johns Hopkins Kimmel Cancer Center in the Greater Washington Area and an associate professor at the School of Medicine. Dr. Pishvaian is a fellowship-trained gastrointestinal oncologist specializing in pancreatic and refractory colorectal cancers. He is committed to precision medicine and provides his patients with the most appropriate and advanced level of care. He conducts all phases of clinical trials for all GI cancers and enrolls qualifying patients. Click here to learn more about oncology clinical trials the Greater Washington Area. Dr. Pishvaian is rated as an Advanced provider by MediFind in the treatment of Adult Soft Tissue Sarcoma. He is also highly rated in 26 other conditions, according to our data. His clinical expertise encompasses Pancreatic Cancer, Colorectal Cancer, Familial Pancreatic Cancer, Pancreaticoduodenectomy, and Pancreatectomy. Dr. Pishvaian is board certified in American Board Of Internal Medicine.

Felasfa Wodajo is an Orthopedics provider practicing medicine in Fairfax, Virginia. Dr. Wodajo is rated as a Distinguished provider by MediFind in the treatment of Adult Soft Tissue Sarcoma. He is also highly rated in 27 other conditions, according to our data. His clinical expertise encompasses Bone Tumor, Ewing Sarcoma, Hemangiopericytoma, Osteochondroma, and Hip Replacement.

Timothy Mccarthy is a Hematologist and an Oncologist practicing medicine in Fairfax, Virginia. Dr. Mccarthy is rated as a Distinguished provider by MediFind in the treatment of Adult Soft Tissue Sarcoma. He is also highly rated in 78 other conditions, according to our data. His clinical expertise encompasses Lung Cancer, Pleuropulmonary Blastoma, Familial Colorectal Cancer, and Monoclonal Gammopathy of Undetermined Significance (MGUS).

Matthew Ladra, M.D., M.P.H., leads the dedicated pediatric team for the Johns Hopkins Proton Therapy Center and is the director of pediatric radiation oncology for the Johns Hopkins Kimmel Cancer Center, a clinical collaboration with Children’s National Hospital, where Dr. Ladra serves as faculty in the department of pediatric oncology. He is also an assistant professor of radiation oncology and molecular radiation sciences at the Johns Hopkins School of Medicine. Listen Dr. Ladra's Cancer Matters podcast episode to learn more about his work. Previously, Dr. Ladra served as the director of pediatric radiation at the Provision Center for Proton Therapy in Tennessee. He also completed a 2-year fellowship in pediatric proton therapy at the Massachusetts General Hospital’s Francis H. Burr Proton Center. Dr. Ladra is one of a handful of radiation oncologists whose research and clinical efforts focus exclusively on pediatric patients. He is frequently invited to speak on pediatric radiation oncology topics internationally and across the U.S. and has published extensively on the subject through original research book chapters and review articles. Dr. Ladra’s research efforts focus mainly on pediatric rhabdomyosarcoma treatment, early phase clinical trials involving radiation and non-chemotherapeutic agents, and reducing neurocognitive toxicity for pediatric brain tumor patients. LinkedIn https://www.linkedin.com/in/matthew-ladra-3094a316. Dr. Ladra is rated as an Advanced provider by MediFind in the treatment of Adult Soft Tissue Sarcoma. He is also highly rated in 7 other conditions, according to our data. His clinical expertise encompasses Rhabdomyosarcoma, Muscle Invasive Bladder Cancer, Adult Soft Tissue Sarcoma, and Ependymoma. Dr. Ladra is board certified in American Board Of Radiology.

Curtiland Deville, MD, is the Medical Director of the Johns Hopkins Proton Therapy Center, Clinical Director of Radiation Oncology at Sibley Memorial Hospital, co-director of the Kimmel Cancer Center Prostate Multidisciplinary Clinic at Sibley Memorial Hospital and an Associate Professor at the Johns Hopkins University School of Medicine. Dr. Deville is an expert in proton therapy and a leader in several institutional and national clinical trials. He treats genitourinary malignancies, including prostate cancer, and soft tissue sarcomas, and is dedicated to creating individualized treatment plans for each patient. His research interests involve better targeting tumors through proton and photon therapies and reducing radiation to healthy tissues. He analyzes toxicity rates with modern radiation techniques and uses the most advanced technology for his patients’ care. Dr. Deville is also a Senior Editor for Advances in Radiation Oncology, as well as a reviewer for several journals that focus on radiation oncology. He is an expert on physician workforce diversity and widely published in the field. He is the immediate past Chair of the American Society of Radiation Oncology's Committee on Health Equity, Diversity and Inclusion and Chair of the American Society of Clinical Oncology’s Diversity in Oncology Subcommittee. LinkedIn https://www.linkedin.com/in/curtiland-deville-37133136. Dr. Deville is rated as an Advanced provider by MediFind in the treatment of Adult Soft Tissue Sarcoma. He is also highly rated in 7 other conditions, according to our data. His clinical expertise encompasses Prostate Cancer, Familial Prostate Cancer, Myxoid Liposarcoma, Liposarcoma, and Prostatectomy. Dr. Deville is board certified in American Board Of Radiology.

Karim Boudadi, M.D., is a medical oncologist and hematologist with the Johns Hopkins Kimmel Cancer Center at Sibley Memorial Hospital in Washington, D.C., and an assistant professor in the Department of Oncology at Johns Hopkins University School of Medicine. Listen to Dr. Boudadi’s Cancer Matters podcast episode to learn more about his work. Dr. Boudadi has expertise in treating cancers of the head and neck, including salivary gland cancers, as well as cancers of the esophagus, and bone and soft tissue sarcomas. Having completed dual training in medical oncology and hematology at Johns Hopkins University, Dr. Boudadi also treats patients with benign hematologic conditions or non-cancer related blood disorders, such as anemia, low blood counts, bleeding disorders, and clotting disorders. Dr. Boudadi earned his medical degree from the University of Rochester School of Medicine. He completed a residency in internal medicine at the University of Michigan in Ann Arbor, MI, and went on to serve as a clinical lecturer in the Department of Internal Medicine at the University of Michigan Medical School before joining Johns Hopkins. He then completed dual fellowship training in both hematology and medical oncology at the Johns Hopkins University School of Medicine. Dr. Boudadi's research during his fellowship focused on prostate cancer and immunotherapy. Dr. Boudadi is a member of the American Society of Clinical Oncology, the American Society of Hematology, the American College of Physicians, and the American Medical Association. He is also a member of the Hematology and Oncology Fellowship Selection Committee at The Johns Hopkins University School of Medicine. Dr. Boudadi has extensive clinical trial development experience and has published his work in peer-reviewed journals. His primary research interest is immunotherapy. Recent News Articles and Media Coverage Cancer Matters Podcast: Dr. Bill Nelson discussing the treatment of HPV related head and neck cancers, Johns Hopkins Kimmel Cancer Center Podcasts (May 23, 2019). Dr. Boudadi is rated as an Advanced provider by MediFind in the treatment of Adult Soft Tissue Sarcoma. He is also highly rated in 21 other conditions, according to our data. His clinical expertise encompasses Glioma, Mesenchymoma, Undifferentiated Pleomorphic Sarcoma, Gastrointestinal Stromal Tumor, and Prostatectomy. Dr. Boudadi is board certified in American Board Of Internal Medicine.

Bruce R. Kressel, M.D., is a medical oncologist at Johns Hopkins Kimmel Cancer Center at Sibley Memorial Hospital and an instructor at Johns Hopkins University School of Medicine. In addition to an expertise in breast and lung cancer, Dr. Kressel has an expertise in gynecologic oncology and general medical oncology, with specific focuses on hematologic malignancies including lymphoma, leukemia and myeloma. Dr. Kressel earned his medical degree at Tufts University School of Medicine. He completed a residency in internal medicine at George Washington University School of Medicine, followed by a fellowship in hematology and oncology, also at George Washington University School of Medicine. Dr. Kressel completed a fellowship in oncology at the Georgetown Lombardi Comprehensive Cancer Center as well. Dr. Kressel has been regularly named one of America’s Top Doctors and one of America's Top Doctors for Cancer by Castle Connolly. He has also been named a Top Doctor in the Washington D.C. and Washington-Baltimore areas by Castle Connolly, as well as a Top Doctor by Consumers’ Checkbook Magazine and Washingtonian Magazine. Dr. Kressel is a member of the American Society of Clinical Oncology and the American Society of Hematology. Dr. Kressel has contributed to numerous publications, presentations and clinical trials. Dr. Kressel is rated as an Advanced provider by MediFind in the treatment of Adult Soft Tissue Sarcoma. He is also highly rated in 62 other conditions, according to our data. His clinical expertise encompasses Essential Thrombocythemia, Non-Hodgkin Lymphoma, Gastric Lymphoma, Chronic Lymphocytic Leukemia (CLL), and Splenectomy. Dr. Kressel is board certified in American Board Of Internal Medicine.

Mustafa Abugideiri is a Radiation Oncologist practicing medicine in Fairfax, Virginia. Dr. Abugideiri is rated as an Experienced provider by MediFind in the treatment of Adult Soft Tissue Sarcoma. He is also highly rated in 28 other conditions, according to our data. His clinical expertise encompasses Prostate Cancer, Familial Prostate Cancer, Pleuropulmonary Blastoma, and Breast Cancer.